The chemical substance with the name "c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-d-Arg-NEt2" and CAS number "1647119-61-6" is a synthetic peptide that features a cyclic structure, incorporating various amino acids and a dimethylated amine group. The presence of the cyclic backbone suggests that it may exhibit enhanced stability and bioactivity compared to linear peptides. The specific amino acids included, such as Bua (butyl alanine), Cpa (cyclopropyl alanine), Thi (threonine), Val (valine), Asn (asparagine), and Cys (cysteine), contribute to its unique properties, potentially influencing its interactions with biological targets. The incorporation of d-Arg (D-arginine) may enhance its resistance to enzymatic degradation, while the NEt2 (dimethylamino) group could affect its solubility and overall pharmacokinetics. Such peptides are often studied for their potential therapeutic applications, including in drug design and development, particularly in the fields of oncology and immunology. Further characterization would typically involve assessing its stability, solubility, and biological activity in relevant assays.

c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-d-Arg-NEt2

1647119-61-6: The chemical substance with the name "c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-d-Arg-NEt2" and CAS number "1647119-61-6" is a synthetic peptide that features a cyclic structure, incorporating various amino acids and a dimethylated amine group. The presence of the cyclic backbone suggests that it may exhibit enhanced stability and bioactivity compared to linear peptides. The specific amino acids included, such as Bua (butyl alanine), Cpa (cyclopropyl alanine), Thi (threonine), Val (valine), Asn (asparagine), and Cys (cysteine), contribute to its unique properties, potentially influencing its interactions with biological targets. The incorporation of d-Arg (D-arginine) may enhance its resistance to enzymatic degradation, while the NEt2 (dimethylamino) group could affect its solubility and overall pharmacokinetics. Such peptides are often studied for their potential therapeutic applications, including in drug design and development, particularly in the fields of oncology and immunology. Further characterization would typically involve assessing its stability, solubility, and biological activity in relevant assays.

<p>Peptidic V2R agonist, c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-d-Arg-NEt2, with EC50: 0.07 nM (hV2R), 0.02 nM (rV2R); selective, short-acting.</p>

CAS 1647119-61-6

c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-d-Arg-NEt2

Velmupressin

Ref: TM-TP1473